IL-6 as Therapeutic Target in Inflammation and CVD

April 2022

Publication: Physicians Academy of Cardiovascular Education

Source / Author: PACE - CME

Professor Ridker discusses the CANTOS trial and findings of studies on IL-6 and CV risk to look to the future.

View here